- Report
- October 2025
- 86 Pages
Global
From €4203EUR$4,799USD£3,648GBP
- Report
- September 2025
- 450 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- August 2025
- 165 Pages
Global
From €1971EUR$2,250USD£1,710GBP
- Report
- April 2025
- 387 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- November 2025
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- June 2025
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- January 2026
- 197 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 186 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 194 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 185 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 190 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 184 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 183 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 190 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 186 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 184 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 197 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 185 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 185 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more